Marksans Pharma informs about updates

19 Jun 2025 Evaluate
Marksans Pharma has informed that its wholly owned subsidiary Relonchem has received Marketing Authorization for the product Oxybutynin hydrochloride 2.5mg/5ml Oral Solution from UK Medicines & Healthcare Products Regulatory Agency.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

167.95 -5.35 (-3.09%)
13-Mar-2026 14:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.30
Dr. Reddys Lab 1290.70
Cipla 1313.90
Zydus Lifesciences 906.40
Lupin 2318.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×